Skip to main content
SpringerLink
Log in

Potentiation of amipaque

Epileptogenic activity by neuroleptics

  • Originals
  • Published:
Neuroradiology Aims and scope Submit manuscript

Summary

Experiments conducted on rabbits confirmed that chlorpromazine potentiates the weak epileptogenic action of Amipaque (metrizamide). Chlorpromazine withdrawal for a period of 48 h suppresses this potentiating effect in the rabbit. Neuroleptic drugs should therefore be avoided in patients examined with Amipaque. In patients under chronic treatment, neuroleptics ought to be discontinued at least 48 h before examination with Amipaque. With the doses and methods used in the present study, diazepam was not as effective as phenobarbital in preventing epilepsy produced by Amipaque. When premidication is needed or when convulsions occur after Amipaque examinations, combined diazepam and phenobarbital therapy ought to be instituted in order to achieve the best control of epileptic reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Booker, H. E., Gadstone, G. C.: Serum concentration of Diazepam in subjects with epilepsy. Arch. Neurol. 29, 192–194 (1973)

    Google Scholar 

  2. De Silva, A. F., Koechlin, B. A., Bader, G.: Blood level distribution patterns of Diazepam and its major metabolite in man. J. Pharm. Sci. 55, 692–702 (1966)

    Google Scholar 

  3. Gonsette, R. E.: Biological tolerance of the central nervous system to metrizamide. Acta radiol. Suppl. 335, 25–44 (1973)

    Google Scholar 

  4. Gonsette, R. E.: Metrizamide as contrast medium for myelography and ventriculography. Acta radiol. Suppl. 345, 346–358 (1973)

    Google Scholar 

  5. Grepe, A., Widen, L.: Neurotoxic effect of intracranial subarachnoid application of metrizamide and meglumine iocarmate. An experimental investigation in dogs in neurolept analgesia. Acta radiol. Suppl. 335, 102–118 (1973)

    Google Scholar 

  6. Hindmarsh, T., Grepe, A., Widen, L.: Metrizamide—phenothiazine interaction. Report of a case with seizures following myelography. Acta radiol. Diagn. 16, 129–134 (1975)

    Google Scholar 

  7. Kaada, B.: Transient EEG abnormalities following lumbar myelography with metrizamide. Acta radiol. Suppl. 335, 380–386 (1973)

    Google Scholar 

  8. Kaplan, S. A., Jack, M. L., Alexander, K., Weinfeld, R. E.: Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. J. Pharm. Sci. 62, 1789–1796 (1973)

    Google Scholar 

  9. Piwonka, R. W., Healey, J. F., Rosenberg, F. J.: Personal communication (1975)

  10. Tilly: Personal communication (1974)

  11. Wylie, I. G., Afshar, F., Koeze, T. H.: Results of the use of a new watersoluble contrast medium (metrizamide) in the posterior fossa of the baboon. Brit. J. Radiol. 48, 1007–1012 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Neuropathologie, Université Catholique de Louvain, Belgium

    R. E. Gonsette & J. M. Brucher

  2. Clinique St Pierre, Service de Neurologie-Neurochirurgie, B-1340, Ottignies, Belgium

    R. E. Gonsette

Authors
  1. R. E. Gonsette
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. M. Brucher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonsette, R.E., Brucher, J.M. Potentiation of amipaque. Neuroradiology 14, 27–30 (1977). https://doi.org/10.1007/BF00399884

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00399884

Key words

Search

Navigation